Interacting Drugs |
Oxaprozin vs Angiotensin II Receptor Blockers |
Security Level |
|
Mechanism |
Angiotensin II Receptor Blockers: May enhance the adverse/toxic effect of Nonsteroidal Anti-Inflammatory Agents. Specifically, the combination may result in a significant decrease in renal function. Nonsteroidal Anti-Inflammatory Agents may diminish the therapeutic effect of Angiotensin II Receptor Blockers. The combination of these two agents may also significantly decrease glomerular filtration and renal function. |
Management |
Monitor therapy |
Oxaprozin vs Angiotensin II Receptor Blockers
Post Review about Oxaprozin vs Angiotensin II Receptor Blockers Click here to cancel reply.
Other Interactions of Angiotensin II Receptor Blockers
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.